Operations Overview
Real-time pharmacogenomics review and compliance status across active cohorts.
Syncing…
Total Samples
20
Across all active cohorts
Pending Review
2
10% of samples awaiting decision
High Risk
4
Low evidence or flagged for review
Approved
11
55% cleared by reviewers
Active Projects
View all| Project | Sponsor | Area | Status | |
|---|---|---|---|---|
| 5FU-Onco-Pilot5FU-Onco-Pilot | OncoGenomics Partners | Oncology | Completed | |
| CLP-India-Phase2CLP-India-Phase2 | Anukriti Translational Medicine | Cardiovascular / Antiplatelet | Active | |
| WARF-EU-Phase1WARF-EU-Phase1 | CardioGenix CRO | Thromboembolism | Active |
Audit Activity
Immutable logAudit Pack Generated
system · AuditPack PACK-CLP-IN-2-001
sample_excluded
Dr. Meera Iyer · Sample SAMPLE-COHORT-CLP-IN-2-0009
Sample Reviewed
Dr. Meera Iyer · Sample SAMPLE-COHORT-CLP-IN-2-0004
Sample Reviewed
Dr. Meera Iyer · Sample SAMPLE-COHORT-CLP-IN-2-0001
Sample Flagged
pgx-engine · Sample SAMPLE-COHORT-CLP-IN-2-0004
engine_run_completed
pgx-engine · Cohort COHORT-CLP-IN-2
Review Queue
2 awaiting decision| Sample | Drug | Gene | Phenotype | Evidence | |
|---|---|---|---|---|---|
| CLP-IN-0018 | Clopidogrel | CYP2C19 | Rapid metabolizer | Medium | |
| CLP-IN-0019 | Clopidogrel | CYP2C19 | Intermediate metabolizer | Medium |